Researchers have completed the first phase of a collaboration integrating robotic cell processing with automated ...

Cell and gene therapy (CGT) manufacturers can struggle to move from lab-scale to clinical-scale production. Automation can help but, to make a success of the transition, developers must be willing to ...

Reducing manual touchpoints is an important part of supporting more consistent and scalable manufacturing processes.

KARLSKOGA, Sweden, Nov. 6, 2025 /PRNewswire/ -- Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success in the Field of Hydrogen.

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

Engineers have created new technology that can move cells without touching them, enabling critical tasks that currently require large pieces of lab equipment to be carried out on a benchtop device.

To start off, could you introduce yourselves and Unicorn Biotechnologies? Jack: I’m Jack, one of the co-founders of Unicorn Biotechnologies. My background is in chemistry, and I’ve worked across ...

There’s an elephant in the room when it comes to cell therapy. Hundreds of thousands of patients are in need of these life saving therapies - but the vast majority can’t access the treatment. This is ...

CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...

In this video, Analytik Jena demonstrates how its advanced liquid handling technology—specifically the CyBio Felix platform—enhances and simplifies cell-based assay workflows. In collaboration with ...